Study Title
[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy
Study Details
Description:
This is a Phase 1 study is to visualize biodistribution of a PET tracer called [18F]F-AraG (VisAcT) in cancer patients expected to undergo immunotherapy and/or radiation therapy.
Sponsor:
CellSight Technologies
Government Study Link:
NCT03142204 - Click here to see study onClinicalTrials.gov